Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313251519> ?p ?o ?g. }
- W4313251519 endingPage "949" @default.
- W4313251519 startingPage "939" @default.
- W4313251519 abstract "Abstract After experiencing an acute coronary syndrome (ACS), patients are at a high risk of suffering from recurrent ischaemic cardiovascular events, especially in the very early phase. Low density lipoprotein-cholesterol (LDL-C) is causally involved in atherosclerosis and a clear, monotonic relationship between pharmacologic LDL-C lowering and a reduction in cardiovascular events post-ACS has been shown, a concept termed ‘the lower, the better’. Current ESC guidelines suggest an LDL-C guided, step-wise initiation and escalation of lipid-lowering therapy (LLT). Observational studies consistently show low rates of guideline-recommended LLT adaptions and concomitant low rates of LDL-C target goal achievement, leaving patients at residual risk, especially in the vulnerable post-ACS phase. In addition to the well-established ‘the lower, the better’ approach, a ‘strike early and strike strong’ approach in the early post-ACS phase with upfront initiation of a combined lipid-lowering approach using high-intensity statins and ezetimibe seems reasonable. We discuss the rationale, clinical trial evidence and experience for such an approach and highlight existing knowledge gaps. In addition, the concept of acute initiation of PCSK9 inhibition in the early phase is reviewed. Ultimately, we focus on hurdles and solutions to provide high-quality, evidence-based follow-up care in post-ACS patients." @default.
- W4313251519 created "2023-01-06" @default.
- W4313251519 creator A5001892884 @default.
- W4313251519 creator A5001951606 @default.
- W4313251519 creator A5009941681 @default.
- W4313251519 creator A5012893415 @default.
- W4313251519 creator A5017991261 @default.
- W4313251519 creator A5018230836 @default.
- W4313251519 creator A5023572557 @default.
- W4313251519 creator A5025883164 @default.
- W4313251519 creator A5038384001 @default.
- W4313251519 creator A5038996491 @default.
- W4313251519 creator A5048944534 @default.
- W4313251519 creator A5049253920 @default.
- W4313251519 creator A5057062433 @default.
- W4313251519 creator A5065814828 @default.
- W4313251519 creator A5065900517 @default.
- W4313251519 creator A5083612247 @default.
- W4313251519 creator A5091523473 @default.
- W4313251519 date "2022-12-01" @default.
- W4313251519 modified "2023-10-16" @default.
- W4313251519 title "Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy" @default.
- W4313251519 cites W1520609538 @default.
- W4313251519 cites W1546258268 @default.
- W4313251519 cites W1985747185 @default.
- W4313251519 cites W1987990591 @default.
- W4313251519 cites W1996129469 @default.
- W4313251519 cites W2018711158 @default.
- W4313251519 cites W2030060743 @default.
- W4313251519 cites W2038293743 @default.
- W4313251519 cites W2065006368 @default.
- W4313251519 cites W2072190804 @default.
- W4313251519 cites W2106536809 @default.
- W4313251519 cites W2108956796 @default.
- W4313251519 cites W2113890084 @default.
- W4313251519 cites W2123326379 @default.
- W4313251519 cites W2134159541 @default.
- W4313251519 cites W2135647797 @default.
- W4313251519 cites W2159449551 @default.
- W4313251519 cites W2160152341 @default.
- W4313251519 cites W2164089346 @default.
- W4313251519 cites W2169252817 @default.
- W4313251519 cites W2169523655 @default.
- W4313251519 cites W2200285648 @default.
- W4313251519 cites W2230299152 @default.
- W4313251519 cites W2342969428 @default.
- W4313251519 cites W2412613960 @default.
- W4313251519 cites W2589580491 @default.
- W4313251519 cites W2595169180 @default.
- W4313251519 cites W2596179513 @default.
- W4313251519 cites W2609543937 @default.
- W4313251519 cites W2614505034 @default.
- W4313251519 cites W2748800769 @default.
- W4313251519 cites W2760771213 @default.
- W4313251519 cites W2790531075 @default.
- W4313251519 cites W2801534920 @default.
- W4313251519 cites W2889582862 @default.
- W4313251519 cites W2893951801 @default.
- W4313251519 cites W2899997727 @default.
- W4313251519 cites W2907012814 @default.
- W4313251519 cites W2913496062 @default.
- W4313251519 cites W2913925753 @default.
- W4313251519 cites W2914225441 @default.
- W4313251519 cites W2941510061 @default.
- W4313251519 cites W2945524279 @default.
- W4313251519 cites W2963429759 @default.
- W4313251519 cites W2965228237 @default.
- W4313251519 cites W2970625233 @default.
- W4313251519 cites W2971165578 @default.
- W4313251519 cites W2976144989 @default.
- W4313251519 cites W2982219478 @default.
- W4313251519 cites W2984293502 @default.
- W4313251519 cites W3006116566 @default.
- W4313251519 cites W3008174927 @default.
- W4313251519 cites W3012265841 @default.
- W4313251519 cites W3028115716 @default.
- W4313251519 cites W3038367706 @default.
- W4313251519 cites W3044128309 @default.
- W4313251519 cites W3047754308 @default.
- W4313251519 cites W3084153881 @default.
- W4313251519 cites W3087468833 @default.
- W4313251519 cites W3104495732 @default.
- W4313251519 cites W3115254109 @default.
- W4313251519 cites W3116048383 @default.
- W4313251519 cites W3118007133 @default.
- W4313251519 cites W3118166189 @default.
- W4313251519 cites W3119736121 @default.
- W4313251519 cites W3120916025 @default.
- W4313251519 cites W3129818723 @default.
- W4313251519 cites W3131028682 @default.
- W4313251519 cites W3133455401 @default.
- W4313251519 cites W3160081688 @default.
- W4313251519 cites W3162195278 @default.
- W4313251519 cites W3170272938 @default.
- W4313251519 cites W3183857127 @default.
- W4313251519 cites W3190466779 @default.
- W4313251519 cites W3196862885 @default.
- W4313251519 cites W3197217805 @default.